DuckWiseDuckWise Get the app

Archive › PFE

PFE trade ideas: every closed DuckWise idea on Pfizer, Inc.

DuckWise has published 1 idea on Pfizer, Inc. (PFE, Stock) that has closed between June 2020 and July 2020. Each is listed below with the levels published before the position was taken and its result at close — 1 in profit, 0 at a loss.

1closed idea
1 / 0in profit / at a loss
+17.11%average result
50 daystypical holding period
OpenedClosedSideEntryStopProjectionCloseResultDays
Jun 2, 2020Jul 22, 2020Long34.07—4039.90+17.11%50

Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. How results are counted.

PFE questions and answers

Has DuckWise published trade ideas on PFE?

Yes. DuckWise has published 1 idea on Pfizer, Inc. (PFE) that closed between June 2020 and July 2020: 1 closed in profit and 0 at a loss. The average result was +17.11% from the published entry to the published close, dividends included.

What was the latest closed DuckWise idea on PFE?

A long idea opened on June 2, 2020 with an entry of $34.07 and a price projection of $40.00. It closed on July 22, 2020 at $39.90, a result of +17.11% after 50 days.

How long did DuckWise hold its PFE ideas?

The typical PFE idea was held about 50 days from entry to close. DuckWise ideas are swing and position trades, not day trades.

Is there an open DuckWise idea on PFE right now?

Not at the moment. When DuckWise publishes a new idea on PFE, app subscribers get a push notification; it appears on this page once it closes.

Is this page a stock forecast for PFE or a recommendation to buy it?

No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where PFE will trade. The research is general and impersonal, not a recommendation to buy or sell PFE or any other security.

More trade ideas on the record

Every ticker in the archive · Track record by year

About Pfizer, Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. Pays a dividend yield of 5.95% annually.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell PFE or any other security.